XJPX
4350
Market cap96mUSD
Oct 09, Last price
514.00JPY
1D
-1.53%
1Q
3.84%
Jan 2017
18.98%
IPO
337.45%
Name
Medical System Network Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Sapporo, Japan, and established in 1999, Medical System Network Co., Ltd. functions as a comprehensive provider within the healthcare industry. Its core business involves the distribution of pharmaceutical products to a diverse range of clients, including pharmacies, hospitals, clinics, and drug wholesalers. The company's operations are divided into several key segments. The Community Pharmacy Network division primarily facilitates the procurement and sale of pharmaceuticals among pharmacies, hospitals, clinics, and wholesale distributors. This segment also delivers crucial inventory management and liquidation services, manufactures and markets its own pharmaceutical offerings, and handles price negotiations with suppliers. Furthermore, it maintains a specialized platform designed to assist with pharmacy transitions. Within the Leasing and Facility-related segment, Medical System Network provides building rental services, develops optimal locations for new pharmacies, and offers consulting expertise to medical practitioners. The Meal Catering segment is responsible for delivering food services to hospitals and various welfare facilities. Beyond these primary areas, the company also offers nursing care and specialized advisory counseling services tailored for the medical treatment sector.
Key people
Eiji Hirashima
Managing Executive Officer, Chief Director of Accounting and Finance, Director · since 2021
Yoshihiro Tanaka
Vice President, Representative Director · since 2021
Kiyoshi Ozawa
Executive Director · since 2014
Yozo Kato
Executive Officer · since 2017
Kentaro Tago
Executive Officer, Chief Director of Business Strategy, President of Subsidiary, Representative Director · since 2020
Hirofumi Uesaka
Executive Officer, Manager of Internal Auditing Office · since 2017
Shuhei Yamada
Executive Officer, Chief Director of Pharmacy Business · since 2017
Jiro Akino
Vice President, Representative Director · since 2015
Akira Aoyama
Managing Executive Officer, Chief Director of System, Director · since 2022
Ryuichi Kawashima
Senior Managing Executive Officer, Chief Director of Accounting & Finance, Director · since 2017
Director · since 2019
Makoto Sakashita
Senior Managing Executive Officer, Chief Director of Administration, Chief Director of Medical Welfare Support, Director · since 2017
Kenji Shimizu
Executive Officer, Chief Director of SCM Business, Director · since 2023
Kazuhiko Sumi
Managing Executive Officer, Director · since 2022
Inao Tajiri
President, Chairman of Subsidiary, Representative Director · since 2020
Toshiko Ibe
Independent Director · since 2019
Independent Director · since 2019
Independent Director · since 2015
Yuji Maeda
Independent Director · since 2023
Satoshi Sato
Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||